Redeployment of BAEs

Discussion in 'Alnylam Pharmaceuticals' started by anonymous, May 22, 2020 at 1:16 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Redeployment
    Redeployment is a staffing reduction strategy that involves reassigning positions. The reassignment may or may not result in changes to:

    • Work duties
    • Work unit
    • Geographic location
    Redeployment typically occurs as a result of good faith reorganization or program elimination.

    Factors to consider when redeploying filled positions include:

    • Change Management. How will the perceptions of impacted employees be managed? How will morale be sustained in light of changing duties, expectations, and the environment?
    • Performance Management. How will staff be informed of new expectations? How will new position descriptions and performance plans be shared with staff? What will be the new performance measures and targets?
    • Job Assignments. Can staff assignments be redistributed within the work unit in a way that takes advantage of existing knowledge and skills?
    • Competencies. Do impacted staff satisfy the competencies and other requirements of the new positions? Can impacted staff be retrained within a reasonable timeframe? If not, impacted staff must be given layoff rights per the employer's layoff procedure.
    • Geographic Location. Will impacted staff be relocated to a new duty station? Is the new duty station within a reasonable commute distance according to the employer's layoff procedure? If not, impacted staff may need to be laid off and given layoff rights per the layoff procedure.
     

  2. anonymous

    anonymous Guest

    Yep, happening in Q3 and effective in Q4.
     
  3. anonymous

    anonymous Guest

     
  4. anonymous

    anonymous Guest

    Always thought this would be an extremely risky position - looks like it is becoming exactly that. Best of luck to those who took the risk...
     
  5. anonymous

    anonymous Guest

    you all need some serious sales leadership with experience kicking some Pfizer and Akcea ass. You all are pathetic.
     
  6. anonymous

    anonymous Guest

    Hope you all are inspired after today’s training... better start selling & stop whining
     
  7. anonymous

    anonymous Guest

    Which therapeutic area is this discussion referring to?
     
  8. anonymous

    anonymous Guest

    Combining ON and GO teams. Not enough SFs to justify the expansion.
     
  9. anonymous

    anonymous Guest

    Actually, Tolga wants to combine the GO and LU teams since they are such "ultra rare" indications. Look for a redeployment after the "Summer Recharge".
     
  10. anonymous

    anonymous Guest

    You nether work here nor posses intelligence. Tolga refers to hATTR as specialty +. Go back to your big pharma mommy’s basement.
     
  11. anonymous

    anonymous Guest

    Makes sense.
     
  12. anonymous

    anonymous Guest

    No word yet.................
     
  13. anonymous

    anonymous Guest

    SO looking forward to the realignment and the upcoming Virtual meeting.
     
  14. anonymous

    anonymous Guest

    Current rumor mill bets that TG will become the Onpattro lead and GO/LU will be merged together with smaller territories carrying both products.
     
  15. anonymous

    anonymous Guest

    Maybe the East SD but OX launch sucked so bad - BUL will go to an outsider - if NF gets SD - many departures will follow
     
  16. anonymous

    anonymous Guest


    WHEN??? I am starving out here.
     
  17. anonymous

    anonymous Guest

    this didn’t age well either.
     
  18. anonymous

    anonymous Guest

    FINALLY it has happened.